approached significanceP = 0.056
The rate of total metachronous advanced adenoma in those with TA with SSL was also higher than the TA only cohort and approached significance (12.8% (5/39) versus 5.2% (59/113)); P = 0.056, respectively.
The rate of total metachronous advanced adenoma in those with TA with SSL was also higher than the TA only cohort and approached significance (12.8% (5/39) versus 5.2% (59/113)); P = 0.056, respectively.